Send us Feedback

Shire Ltd (LON:SHP)
Analysis
SUMMARY
BULLS
BEARS
Data
STOCK CHART
QUOTE AND NEWS
Festival Attendees to Participate in Real Life Tolkien-Inspired Battle
Marketwire  Aug 5  Comment 
WALES, UNITED KINGDOM -- (Marketwire) -- 08/05/10 -- The clash of swords against shields will be heard around mid Wales this summer as attendees at Festival in the Shire (August 13th to 15th, Pafiliwn Bont, Pontrhydfendigaid) battle for Middle Earth.
Rick Wakeman to Play at Festival in the Shire
Marketwire  Jul 1  Comment 
WALES, UNITED KINGDOM -- (Marketwire) -- 07/01/10 -- National Pavilion Wales Pontrhydfendigaid, Wales, United Kingdom, SY25 6BB: Festival in the Shire is pleased to announce the main music performance on Sunday evening; Rick Wakeman. Rick, who is




more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Vanden Bowen

Shire Ltd., formerly Shire plc, is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. In June 2007, the Company received an approvable letter from the United States Food and Drug Administration (FDA) for INTUNIV (guanfacine) extended release tablets (previously referred to as SPD503), a non-stimulant selective alpha-2A-receptor agonist. On November 7, 2007, Shire entered into a license agreement with Amicus Therapeutics, Inc. (Amicus), under which it received the rights to three compounds, PLICERA, AMIGAL and AT2220, in markets outside the United States. In April 2008, Shire announced the acquisition of arylsulfatase-A (ASA), an enzyme replacement therapy (ERT) in Phase I-II clinical trials for metachromatic leukodystrophy (MLD) from the Danish company, Zymenex A/S.

Retrieved from "http://www.wikinvest.com/stock/Shire_Ltd_(LON:SHP)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki